Hologic subsidiary gets tenders for 95.8% of Third Wave shares

By Jennifer Chiou

New York, July 24 - Hologic, Inc. subsidiary Thunder Tech Corp. said it obtained tenders for 47,968,050 shares, or about 95.8%, of Third Wave Technologies, Inc. common stock by the end of the subsequent offering period for all the remaining Third Wave shares at the same $11.25-per-share price paid in the original offer.

The subsequent offering period ended at midnight ET on July 23.

All validly tendered shares were accepted for payment.

Before the subsequent offering period, on July 17, Hologic said it accepted 45,225,950 shares, or about 92.1%, of Third Wave common stock in the tender offer ended at midnight ET on July 16. The offer began on June 18.

Any untendered Third Wave shares will be converted into the right to receive $11.25 per share in cash.

The effective date of the merger was expected to be Thursday, according to a Hologic news release.

As previously reported, Hologic agreed to acquire Third Wave for $580 million in a bid to accelerate the growth of Hologic's diagnostics division.

The Federal Trade Commission granted early termination of the Hart-Scott-Rodino waiting period in June in connection with the merger.

Hologic is a Bedford, Mass.-based medical technologies company. Based in Madison, Wis., Third Wave develops molecular diagnostic reagents.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.